["{\n\"step_by_step_thinking\": \"The patient presents with muscle pain and weakness after being started on rosuvastatin. Stopping the statin resolves his symptoms. This suggests a possible myotoxic effect of the statin. There is no mention of other risk factors such as kidney or liver disease that could have contributed to this issue. The patient's LDL control needs to be reassessed. A different statin may not be an option given the potential for similar adverse effects. Fenofibrate is not a suitable alternative as it has its own set of side effects and is not specifically indicated for high cholesterol management. Fish oils are not a direct treatment for hyperlipidemia but can be used in combination with statins to reduce triglycerides. Therefore, restarting rosuvastatin at a lower dose seems the most logical option.\",\n\"answer_choice\": \"A\""]